Pharmaceutical Journal

Striving to stall Parkinson’s disease

First described 200 years ago, Parkinson’s disease remains without a cure. After many failed clinical trials, researchers are getting back to basics to try to gain a better understanding of the challenges, and a new generation of treatment ideas are now in clinical trials, some of which aim to stall progression of the disease.

Read this story at Pharmaceutical Journal.

%d bloggers like this: